New study pits two therapies against each other for stubborn depression
NCT ID NCT04996433
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two types of talk therapy—CBASP and Behavioral Activation—for adults with long-lasting depression that hasn't improved with other treatments. About 396 inpatients will receive 16 weeks of one therapy to see which works better and why. The goal is to find more effective ways to ease symptoms in people with treatment-resistant depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité, University Medicine Berlin
RECRUITINGBerlin, State of Berlin, 10117, Germany
-
Klinikum der Universität München
RECRUITINGMünchen, 80336, Germany
-
Medizinische Hochschule Hannover
TERMINATEDHanover, 30625, Germany
-
Universität zu Lübeck
RECRUITINGLübeck, 23562, Germany
-
Universitätsklinikum Bonn
RECRUITINGBonn, 53127, Germany
-
Universitätsklinikum Jena
RECRUITINGJena, 07743, Germany
-
Universitätsklinikum Marburg
RECRUITINGMarburg, 35039, Germany
-
Universitätsklinikum Tübingen
RECRUITINGTübingen, 72076, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain 'Radio' tunes into Depression's neural signals
- Magic mushroom compound tested for dual relief of chronic pain and depression
- Brain scans may predict which kids respond to family therapy for depression
- Ketamine plus talk therapy shows promise for stubborn depression
- Brain zaps guided by scans: a new hope for untreatable depression?
- Gut feeling: could a probiotic ease depression in young brains?